| Name
|
Dr. Anil Kumar Rastogi |
| |
|
| Designation
|
Area
Coordinator, Leishmaniasis & Head Biochemistry Division |
| |
|
| Field
of specialization |
Biochemistry |
| |
|
Current
research
interests |
Molecular aspects of leishmanial infections |
| - |
|
| - |
| Important
recent publications: |
| |
|
 |
Characterization
of kDNA minicircles of an Indian Isolate of Leishmania
donovani- Acta
Tropica (1999); 73, 313-319.
|
| |
|
|
Characterization
of intracellular metabolites of axenic amastigotes
of Leishmania
donovani by 1[H] NMR spectroscopy. Acta Tropica
(1999); 73, 121-133. |
| |
|
|
Kinetoplast
DNA minicircle of Leishmania donovani expresses
a protein product. Biochim. Et. Biophys. Acta
(1999); 1444, 263-268. |
| |
|
|
Antigenic
definition of plasma membrane proteins of Bacillus
Calmette Guerin: Predominant activation of human
T cells by low molecular weight integral protein
- submits. Clin. &
Exp. Immunol. Scand. J. Immunol. (1999); 50, 411-419.
|
| |
|
|
Protective
effect of Picroliv from Picrorhiza kurroa
against Leishmania donovani infection in
Mesocricetus auratus.
Life Sciences (1998); 63 1823-1834. |
| |
|
|
| |
| Patents: |
| |
US
Patent No.
09-280448 |
A
method of treating hypolipidemic and hypoglycemic activities
in mammals using pregnadienols and pregnadiemanes. |
| |
|
European
Patent No.
99 3025556, 8-2112 |
Medicaments
for hypolipidemic and hypoglycemic conditions. |
| - |
|
